Clinical Trial Update: Microencapsulated Fish Oil or Conjugated Linoleic Acid in Metabolic Syndrome [NA]

View source ↗

Summary

Completed clinical trial investigating microencapsulated fish oil or conjugated linoleic acid in metabolic syndrome, focusing on insulin resistance, oxidative s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Conjugated Linoleic Acid (Conjugated linoleic acid)
• Microencapsulated fish oil (Omega-3 fatty acids (EPA/DHA))

Snippet

Sponsor: Universidade Federal do Rio de Janeiro | Conditions: Insulin Resistance, Oxidative Stress | NA | Status: COMPLETED